CNS Drugs

Informed Consent and Antipsychotic Use in Patients with Schizophrenia: Issues and Recommendations
pp. 1-5(5)
Authors: Laugharne J.; Brown S.

Melatonin in Cluster Headache: Rationale for Use and Possible Therapeutic Potential
pp. 7-16(10)
Authors: Leone M.; Bussone G.

Diagnosis and Treatment of Geriatric Depression
pp. 17-30(14)
Authors: Lasser R.; Siegel E.; Dukoff R.; Sunderland T.

AIDS Dementia Complex: Diagnosis and Drug Treatment Options
pp. 31-40(10)
Authors: Portegies P.; Rosenberg N.R.

Drug-Induced Behavioural Disinhibition: Incidence, Mechanisms and Therapeutic Implications
pp. 41-57(17)
Author: Bond A.J.

From Rodents to Recovery: Development of Animal Models of Schizophrenia
pp. 59-68(10)
Author: Higgins G.A.

Eptastigmine
pp. 69-75(7)
Authors: McClellan K.J.; Benfield P.

Eptastigmine: A Viewpoint by Daniela Braida
pp. 76-76(1)
Author: Braida D.

Eptastigmine: A Viewpoint by Massimo Franceschi
pp. 76-76(1)
Author: Franceschi M.